Cargando…
Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
BACKGROUND: Diffuse parenchymal lung diseases (DPLD) in children represent a rare and heterogeneous group of chronic pulmonary disorders. Despite substantial advances in genetics and pathomechanisms, these often lethal diseases are still under-diagnosed. This is due to the fact that (i) the incidenc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800105/ https://www.ncbi.nlm.nih.gov/pubmed/20003372 http://dx.doi.org/10.1186/1750-1172-4-26 |
_version_ | 1782175838120181760 |
---|---|
author | Griese, Matthias Haug, Melanie Brasch, Frank Freihorst, Achim Lohse, Peter von Kries, Rüdiger Zimmermann, Theodor Hartl, Dominik |
author_facet | Griese, Matthias Haug, Melanie Brasch, Frank Freihorst, Achim Lohse, Peter von Kries, Rüdiger Zimmermann, Theodor Hartl, Dominik |
author_sort | Griese, Matthias |
collection | PubMed |
description | BACKGROUND: Diffuse parenchymal lung diseases (DPLD) in children represent a rare and heterogeneous group of chronic pulmonary disorders. Despite substantial advances in genetics and pathomechanisms, these often lethal diseases are still under-diagnosed. This is due to the fact that (i) the incidence is low, and (ii) clinical presentation, (iii) disease classification and (iv) specific treatment options are largely unknown. METHODS: Here we systematically assessed the incidence, the presentation, the diagnostic yield and treatments of pediatric DPLD in Germany, using the Surveillance Unit for Rare Paediatric Disorders (ESPED). RESULTS: The incidence of DPLD was 1.32 new cases per 1 million of children per year. The majority of these children were diagnosed within the first year of life. Overall survival was 87%. Using centralized data entry and stratification tools, the patients were categorized into an advanced classification system based on diagnostic algorithms, including clinical presentations, genetics and/or histology. Combining molecular and clinical information, this survey provides an etiological overview and specific diagnostic recommendations for children with DPLD. CONCLUSIONS: Standardized surveys and systematic classifications are valuable tools for the clinical handling of children with DPLD and aim to improve the disease understanding and the prognosis of these rare detrimental lung diseases. |
format | Text |
id | pubmed-2800105 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28001052009-12-31 Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany Griese, Matthias Haug, Melanie Brasch, Frank Freihorst, Achim Lohse, Peter von Kries, Rüdiger Zimmermann, Theodor Hartl, Dominik Orphanet J Rare Dis Research BACKGROUND: Diffuse parenchymal lung diseases (DPLD) in children represent a rare and heterogeneous group of chronic pulmonary disorders. Despite substantial advances in genetics and pathomechanisms, these often lethal diseases are still under-diagnosed. This is due to the fact that (i) the incidence is low, and (ii) clinical presentation, (iii) disease classification and (iv) specific treatment options are largely unknown. METHODS: Here we systematically assessed the incidence, the presentation, the diagnostic yield and treatments of pediatric DPLD in Germany, using the Surveillance Unit for Rare Paediatric Disorders (ESPED). RESULTS: The incidence of DPLD was 1.32 new cases per 1 million of children per year. The majority of these children were diagnosed within the first year of life. Overall survival was 87%. Using centralized data entry and stratification tools, the patients were categorized into an advanced classification system based on diagnostic algorithms, including clinical presentations, genetics and/or histology. Combining molecular and clinical information, this survey provides an etiological overview and specific diagnostic recommendations for children with DPLD. CONCLUSIONS: Standardized surveys and systematic classifications are valuable tools for the clinical handling of children with DPLD and aim to improve the disease understanding and the prognosis of these rare detrimental lung diseases. BioMed Central 2009-12-12 /pmc/articles/PMC2800105/ /pubmed/20003372 http://dx.doi.org/10.1186/1750-1172-4-26 Text en Copyright ©2009 Griese et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Griese, Matthias Haug, Melanie Brasch, Frank Freihorst, Achim Lohse, Peter von Kries, Rüdiger Zimmermann, Theodor Hartl, Dominik Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany |
title | Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany |
title_full | Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany |
title_fullStr | Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany |
title_full_unstemmed | Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany |
title_short | Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany |
title_sort | incidence and classification of pediatric diffuse parenchymal lung diseases in germany |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800105/ https://www.ncbi.nlm.nih.gov/pubmed/20003372 http://dx.doi.org/10.1186/1750-1172-4-26 |
work_keys_str_mv | AT griesematthias incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany AT haugmelanie incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany AT braschfrank incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany AT freihorstachim incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany AT lohsepeter incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany AT vonkriesrudiger incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany AT zimmermanntheodor incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany AT hartldominik incidenceandclassificationofpediatricdiffuseparenchymallungdiseasesingermany |